Product Details
Active Ingredient
Gefitinib
Pack Configuration
3 X 1 X 10 Tablets
Administration Route
Oral
Tablet Coating
Film-Coated
Colouring Agent
Titanium Dioxide IP
Therapeutic Group
Antineoplastic Agent
Pharmacological Class
EGFR Tyrosine Kinase Inhibitor
Primary Application
Non-Small Cell Lung Cancer
Storage Requirement
Below 25°C
Protection
Protect From Light & Moisture
Prescription Status
Oncologist Prescription Required
Manufacturer
Hetero Labs Limited
Marketer
Zydus Lifesciences Limited
We offer Geffon Gefitinib 250mg Tablets, a sought-after product in the pharmaceutical industry by manufacturers, exporters, and suppliers. This powerful antineoplastic agent contains 250mg of Gefitinib in a convenient tablet form. Each pack includes 10 film-coated tablets with a titanium dioxide IP coloring agent, packaged in 3 X 1 X 10 configuration for easy dispensing. Designed for oral administration, these tablets are a crucial component in cancer treatment regimens. Ideal for B2B buyers sourcing high-quality oncology medications, our Geffon Gefitinib Tablets meet stringent quality standards and provide effective therapeutic outcomes.